Soken Chemical Rolls Out Emergency Takeover Defense as Axium Capital's Stake Hits 22.6%
A Singapore fund's stake in Soken Chemical has reached 22.60%, above the roughly 20% needed to block special-resolution votes at the company's annual meeting, and Soken's new defense plan sets out notice periods and a board review window, run past an independent committee, before any further buying toward 23% can proceed.